title: Methylnaltrexone and gastrointestinal perforation.
authors.forename: Ann Corken
authors.initials: AC
authors.lastname: Mackey
authors.forename: Lanh
authors.initials: L
authors.lastname: Green
authors.forename: Patty
authors.initials: P
authors.lastname: Greene
authors.forename: Mark
authors.initials: M
authors.lastname: Avigan
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects / Q000037:antagonists & inhibitors; D006801:Humans; D007416:Intestinal Perforation / Q000139:chemically induced* / Q000453:epidemiology; D009271:Naltrexone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D010166:Palliative Care; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009271:Naltrexone